Overall Technical outlook

Price Summary

On 2025-07-16, SUVENPHAR's stock opened at 1059.0, reached a peak of 1071.95, dropped to 1054.4, and ended 0.45% higher at 1063.8, with a volume of 191992 shares.
The stock's peak price over the last 52 weeks is 1063.8, with the lowest being 944.1.

Technicals

Support and Resistance: The price for SUVENPHAR at 1063.8 finds support at 1048.2 and resistance at 1113.1. This suggests a trading range, where 1048.2 serves as a support level and 1113.1 acts as a resistance point, potentially capping further gains.
SUVENPHAR supportResistance cffe81
Support/Resistance for SUVENPHAR


Aroon: The current state of the AROON is neutral, with no clear trend direction indicated. This lack of directional bias suggests that the market may be in a phase of consolidation or uncertainty.
SUVENPHAR aroon cffe81
Aroon chart for Suven Pharmaceuticals Limited


Bol. Bands: In the latest price action for SUVENPHAR, the current price has surpassed the upper Bollinger Band, indicating a bullish breakout. This movement suggests that buying pressure has intensified, driving the price beyond its typical range. Traders often view this as a positive signal, suggesting that the market might continue to rise as momentum builds.
SUVENPHAR bbands cffe81
Bolinger Bands chart for Suven Pharmaceuticals Limited


Parabolic SAR: The PSAR remains bullish in its outlook, setting a key support level that could sustain the ongoing upward trend. This strong support indicates that the market may continue to rise, with the bullish momentum likely to persist for SUVENPHAR.
SUVENPHAR psar cffe81
Parabolic Stop and Reverse chart for Suven Pharmaceuticals Limited


Stochastic: The stochastic indicator for Suven Pharmaceuticals Limited reflects a bullish sentiment, as the K-line is above both the D-line and the 80 threshold. This setup points to strong upward momentum, implying that the market may continue to rise. Traders could consider this as an indication of sustained bullish activity.
SUVENPHAR stoch cffe81
Stochastic chart for Suven Pharmaceuticals Limited


Tripple Moving Agerage: The current state of the Tripple MOVING AVG is neutral, with no clear trend direction indicated. This lack of directional bias suggests that the market may be in a phase of consolidation or uncertainty.
SUVENPHAR trippleSMA cffe81
Tripple SMA chart for Suven Pharmaceuticals Limited


When evaluating a company's technical data, such as stock price charts or volume, it is essential to first consider its fundamentals. These fundamentals include financial stability, growth potential, and competitive advantages. Additionally, understanding the broader industry in which the company operates offers context that helps to make sense of technical patterns. By examining both the company's internal strengths and external environment, one can make more accurate and meaningful conclusions about its stock performance.